PSX vs STRO
Phillips 66 (PSX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PSX currently screens at market cap $67.02B and trailing P/E 16.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PSX and STRO stock pages for the full models.
Not investment advice.